Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma |
| |
Authors: | Zorica Cvetković Vesna Vučić Bora Cvetković Milan Petrović Danijela Ristić-Medić Jasna Tepšić Maria Glibetić |
| |
Affiliation: | 1. Department of Hematology, Clinical Hospital Center Zemun, Vukova 9, 11080, Belgrade, Serbia 2. Institute for Medical Research, Department for Nutrition and Metabolism, University of Belgrade, Tadeusa Koscuska 1, 11129, Belgrade, Serbia 3. Department of Urology, Clinical Hospital Center Zemun, Vukova 9, 11080, Belgrade, Serbia 4. Institute for Hematology, Clinical Center of Serbia, Pasterova 2, 11000, Belgrade, Serbia
|
| |
Abstract: | The data about the fatty acid (FA) status of non-Hodgkin lymphoma (NHL) patients are poor. Therefore, the aim of this study was to investigate the FA profile of serum phospholipids in NHL patients related to the aggressiveness and clinical stage of NHL. We analyzed the FA profile of serum phospholipids in 47 newly diagnosed, untreated NHL patients and in 29 healthy subjects. Significantly higher (p?0.001) levels of palmitic (16:0), oleic (18:1 n-9) and arachidonic acids (20:4 n-6), saturated and monounsaturated FA were found in NHL patients, while linoleic acid (18:2 n-6) and the levels of total polyunsaturated FA (PUFA), n-3 PUFA, eicosapentaenoic (20:5 n-3) and docosahexaenoic (DHA, 22:6 n-3) were significantly reduced (p?0.01). The level of oleic acid in patients with indolent NHL was significantly lower (p?0.05) than in more aggressive types of disease. Contents of palmitoleic acid, docosatetraenoic (22:4 n-6), and PUFA was lower in very aggressive NHL. According to clinical stage (CS), patients with CS I had significantly higher SFA and lower n-6 FA than other three groups, and group with CS IV showed significantly decreased DHA and n-3 PUFA. Our results showed an abnormal FA profile in serum phospholipids in NHL patients. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|